CNSide Diagnostics, LLC is a company dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays.  The first-in-class CNSide™ assay is performed in a CLIA-registered facility in Houston, Texas at the request of top cancer physicians in the U.S.

CNSide™ is a highly sensitive, cerebrospinal fluid-based, laboratory developed test (LDT) for patients with Leptomeningeal Metastases (LM) from carcinomas and melanomas.  By enabling quantitative analysis and molecular characterization of tumor cells, we provide powerful insights to healthcare providers that guide patient care and treatment decisions.

CNSide Diagnostics

Org chart

Teams

Offices

Similar companies